期刊文献+

瑞舒伐他汀钙对冠心病患者行冠状动脉造影术后肾功能的保护作用及其机制 被引量:13

Renal protective effect and its mechanism of actions of rosuvastatin calcium in patients with coronary heart disease after angiography
原文传递
导出
摘要 目的:研究瑞舒伐他汀钙对冠状动脉造影术后冠心病患者的肾功能保护作用,并探讨其作用机制。方法:选择行冠状动脉造影术的182例患者随机分为观察组与对照组。2组患者仅观察组患者术前3 d开始服用瑞舒伐他汀钙40 mg·d-1。比较2组患者手术前后肾脏功能及血清炎性细胞因子水平。结果:术前2组患者血肌酐(Scr)、血清胱抑素(Cys-c)、β2-微球蛋白(β2-MG)和脂质运载蛋白(NGAL)水平差异无统计学意义(P>0.05),术后第1天、第2天和术后第5天观察组患者(CysC、β2-MG和NGAL水平均显著低于对照组(P<0.01),但是Scr水平仅对照组术后第2天显著低于对照组(P<0.01)。术后对照组和观察组分别有5例(5.49%)和0例(0%)患者出现造影剂肾病(CIN),差异具有统计学意义(P<0.05)。术前2组患者高敏C-反应蛋白(Hs-CRP)、白介素-6(IL-6)和肿瘤坏死因子(TNF-α)水平差异无统计学意义(P>0.05),但是术后第1天、第2天和术后第5天观察组患者上述炎性细胞因子水平均显著低于对照组(P<0.01)。结论:瑞舒伐他汀钙早期干预对冠心病患者行冠状动脉造影术患者的肾功能具有保护作用,其机制可能与减轻造影剂导致的炎症反应有关。 OBJECTIVE To investigate the renal protective effect of rosuvastatin calcium on renal damage induced by contrast agent of angiography and to explore its mechanism of actions. METHODS 182 patients with coronary heart disease received angiography were randomly divided into observation group and control group. Cases in observation group were given with rosuvastatin calcium 40 mg. d^- 1. The indicators of renal function and the level of serum inflammatory cytokines were compared before and after operation. RESULTS The levels of Scr, Cys-c, β2-MG and NGAL in observation group were not significantly different compared with those in control group before operation (P〉0. 05). The levels of Cys-c, β2-MG and NGAL in observation group were significantly lower than control group in 1st, 2nd and 5th day after operation (P〈0. 01), and the level of Scr were significantly lower than control group in 2nd day after operation (P〈0. 01). There were respectively 5 cases (5.49%) and no case (0%) with CIN after operation with difference in statistic (P〈0. 05). The levels of Hs-CRP, IL-6 and TNF-a in observation group were not significantly different compared with those in control group before operation (P〉0. 05). The levels of Hs-CRP, IL-6 and TNF-a in observation group were significantly lower than control group in 1st, 2nd and 5th day after operation (P〈0. 01). CONCLUSION Rosuvastatin calcium has the protective effect on renal damage induced by con- trast agent of angiography, which is probably related to the decrease in the inflammatory reaction induced by contrast agent.
作者 鲍东来
出处 《中国医院药学杂志》 CAS CSCD 北大核心 2014年第3期218-221,共4页 Chinese Journal of Hospital Pharmacy
关键词 瑞舒伐他汀钙 冠状动脉造影 肾脏功能 炎性细胞因子 rosuvastatin calcium angiography of coronary artery renal function inflammatory cytokine
作者简介 [作者简介]鲍东来,男,学士,主治医师,电话:0579—85209666
  • 相关文献

参考文献14

  • 1Weisbord SD, Palevsky PM. Prevention of contrast-induced nephr-opathy with volume expansion [J]. Clin J Am Soc Nephrol, 2008,3 ( 1 ) : 273-280.
  • 2Bellosta S,Ferri N,Bernini F,etal. Non-lipid-related effects of statins[J]. Ann Intern Med, 2000,32 (3) : 164.
  • 3祁春雷,陈还珍,王芳,王丽娟,吴磊.不同剂量阿托伐他汀对对比剂致肾功能损伤短期改善的观察[J].中西医结合心脑血管病杂志,2011,9(3):293-295. 被引量:2
  • 4Trof R J, Dimaggio F, Leenreis J,et al. Biomarkers of acute re- nal injury and renal failure[J]. Shock,2006,26(3):2452.
  • 5陈光铃,王琛,蔡文钦.阿托伐他汀对冠心病患者冠状动脉造影术后超敏C反应蛋白的影响及其对肾功能的保护作用[J].临床心血管病杂志,2011,27(5):355-358. 被引量:11
  • 6杨洁,张海霞,赵东伟,张春晖.参附注射液对肠缺血再灌注大鼠肝肾功能及TNF-α、IL-6水平的影响[J].山东医药,2012,52(19):27-28. 被引量:9
  • 7Qasim AR,Jeffrey HN. Risk of nephropathy after intravenous administration of contrast material..a critical literature analysis [J]. Radiology, 2006,239 (2) : 392-397.
  • 8钟诚,徐耕,金红峰,等.阿托伐他汀对冠心病伴糖尿病患者的肾脏保护作用的临床观察[J].心脑血管病防,2012,12(2):97-100.
  • 9Wallace SM, Mitki-Petaja KM, Cheriyan J, et al. Simvastatin prevents inflammation-induced aortic stiffening and endothelial dysfunction[J]. Br Clin Pharmacol, 2010,70 (6) : 799-806.
  • 10Narvaez Sanchez R, Gonzalez L, Salamanca A. et al. Cystatirt C could be a replacement to serum creatinine for diagnosing and monitoring kidney function in children[J]. Clin Bioehe, 2008, 41(78) :498-503.

二级参考文献27

共引文献19

同被引文献107

  • 1杨慎先,杜长春,李蒙,王枫岭.瑞舒伐他汀强化降脂治疗对冠状动脉临界病变斑块结构的影响[J].中国动脉硬化杂志,2015,23(6):594-598. 被引量:15
  • 2NAKAMURA A, MIURA S, SUGIHARA M, et al. Contrast?be- tween innovator drug-and generic drug-induced renal dysfunction on coronary angiography (CONTRAST study)[J]. Heart Vessels, 2014, 29(5): 603-610.
  • 30ZKAN S, OYSU AS, KAYATAS ter contrast agent administration prospective observational study in K, et al. Thyroid functions af- for coronary angiography: a euthyroid palients[J]. AnadoluKar(tiyol Derg, 2013, 13(4): 363-369.
  • 4VEL.:ZQUEZ MT, ALBARR:N A, HERNANDEZ F, et al. Less iodine injected for the same diagnostic performances: comparison of two low-osmolar contrastagents (iobitrido| 350 and iopamidol 370) in coronary angiogvaphy and ventriculography: a randomized double-blind clinical study[J]. Acta Cavdiol, 2010, 65(4): 387-394.
  • 5MORCOS SK. Prevention of contrastmedia nephrotoxicity-the storyso far[J]. Chn Radio, 2004, 59(5): 381-389.
  • 6AJAMI G, DERAKHSHAN A, AMOOZGAR H, et al. Risk of nephropathy after consumption of nonionie eontrast media by ehildren undergoing eardiaeangiography: a prospective study [J]. Pediatr Cardiol, 2010, 31(5): 668-673.
  • 7STRATFA P, QUAGLIA M, AIROLDI A, et al. Structure-func- tion relationships of iodinated contrast media and risk of nephro- toxicity[J]. Curr Med Chem, 2012, 19(5): 736-745.
  • 8中华人民共和国卫生部.冠状动脉粥样硬化性心脏病诊断标准[S].中华人民共和国卫生行业标准WS319—2010.
  • 9Parra L, Fita G, Gomar C, et al. Plasma magnesium in patients submit- ted to cardiac surgery and its influence on perioperative morbidity [J]. Cardiovasc Surg, 2011,42 ( 10 ) :37 - 42.
  • 10Liu H, Yu N, Lu S, et al. Solute carrier family of the organic anion - transporting polypeptides 1 A2 - Madin - Darby canine kidney II: a promising in vitro system to understand the role of organic anion - trans- porting polypeptide 1A2 in blood - brain barrier drug penetration [J]. Drug Metab Dispos ,2015,43 ( 7 ) : 1008 - 1018.

引证文献13

二级引证文献49

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部